NASDAQ:ZYXI Zynex (ZYXI) Stock Price, News & Analysis $2.41 -0.11 (-4.37%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$2.26 -0.16 (-6.43%) As of 04/25/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Zynex Stock (NASDAQ:ZYXI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Zynex alerts:Sign Up Key Stats Today's Range$2.37▼$2.5750-Day Range$2.11▼$7.5552-Week Range$1.93▼$12.19Volume158,812 shsAverage Volume151,908 shsMarket Capitalization$72.85 millionP/E Ratio16.07Dividend YieldN/APrice Target$10.25Consensus RatingHold Company OverviewZynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.Read More… Zynex Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks56th Percentile Overall ScoreZYXI MarketRank™: Zynex scored higher than 56% of companies evaluated by MarketBeat, and ranked 289th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingZynex has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageZynex has only been the subject of 3 research reports in the past 90 days.Read more about Zynex's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth135.00% Earnings GrowthEarnings for Zynex are expected to grow by 135.00% in the coming year, from $0.20 to $0.47 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Zynex is 16.07, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.72.Price to Earnings Ratio vs. SectorThe P/E ratio of Zynex is 16.07, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.43.Price to Book Value per Share RatioZynex has a P/B Ratio of 1.77. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Zynex's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted21.51% of the float of Zynex has been sold short.Short Interest Ratio / Days to CoverZynex has a short interest ratio ("days to cover") of 15.3, which indicates bearish sentiment.Change versus previous monthShort interest in Zynex has recently increased by 1.06%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldZynex does not currently pay a dividend.Dividend GrowthZynex does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted21.51% of the float of Zynex has been sold short.Short Interest Ratio / Days to CoverZynex has a short interest ratio ("days to cover") of 15.3, which indicates bearish sentiment.Change versus previous monthShort interest in Zynex has recently increased by 1.06%, indicating that investor sentiment is decreasing. News and Social Media1.7 / 5News Sentiment0.08 News SentimentZynex has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 32 news articles for Zynex this week, compared to 6 articles on an average week.MarketBeat FollowsOnly 1 people have added Zynex to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Zynex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $148,300.00 in company stock.Percentage Held by Insiders49.28% of the stock of Zynex is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 29.68% of the stock of Zynex is held by institutions.Read more about Zynex's insider trading history. Receive ZYXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter. Email Address ZYXI Stock News HeadlinesFaruqi & Faruqi Reminds Zynex Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 19, 2025 - ZYXIApril 27 at 8:20 AM | prnewswire.comZynex, Inc. (NASDAQ:ZYXI) Delivered A Weaker ROE Than Its IndustryApril 26 at 12:58 PM | finance.yahoo.comFrom Social Security to Social Prosperity?In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.April 28, 2025 | Paradigm Press (Ad)ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZYXIApril 26 at 12:13 PM | globenewswire.comINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ZynexApril 26 at 9:57 AM | globenewswire.comZynex files $100M mixed securities shelfApril 25 at 11:37 PM | msn.comZYXI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zynex, Inc. ...April 25 at 5:41 PM | gurufocus.comZYXI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zynex, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitApril 25 at 4:00 PM | globenewswire.comSee More Headlines ZYXI Stock Analysis - Frequently Asked Questions How have ZYXI shares performed this year? Zynex's stock was trading at $8.01 at the beginning of 2025. Since then, ZYXI stock has decreased by 69.9% and is now trading at $2.41. View the best growth stocks for 2025 here. How were Zynex's earnings last quarter? Zynex, Inc. (NASDAQ:ZYXI) announced its quarterly earnings results on Tuesday, March, 11th. The company reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of $0.09 by $0.11. The firm had revenue of $45.98 million for the quarter, compared to analysts' expectations of $53.65 million. Zynex had a trailing twelve-month return on equity of 13.05% and a net margin of 2.49%. Read the conference call transcript. Who are Zynex's major shareholders? Top institutional investors of Zynex include Janney Montgomery Scott LLC (0.49%) and Alhambra Investment Management LLC (0.05%). Insiders that own company stock include Thomas Sandgaard, Joshua R Disbrow, Anna Lucsok and Daniel J Moorhead. View institutional ownership trends. How do I buy shares of Zynex? Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Zynex own? Based on aggregate information from My MarketBeat watchlists, some other companies that Zynex investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), AUO (AUOTY) and Humana (HUM). Company Calendar Last Earnings3/11/2025Today4/28/2025Next Earnings (Estimated)4/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:ZYXI CIK846475 Webwww.zynex.com Phone(303) 703-4906FaxN/AEmployees770Year FoundedN/APrice Target and Rating Average Stock Price Target$10.25 High Stock Price Target$15.00 Low Stock Price Target$5.50 Potential Upside/Downside+325.3%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.09 Trailing P/E Ratio16.07 Forward P/E Ratio12.05 P/E GrowthN/ANet Income$9.73 million Net Margins2.49% Pretax Margin3.48% Return on Equity13.05% Return on Assets3.78% Debt Debt-to-Equity Ratio1.66 Current Ratio3.94 Quick Ratio3.15 Sales & Book Value Annual Sales$192.35 million Price / Sales0.38 Cash Flow$0.13 per share Price / Cash Flow18.01 Book Value$1.36 per share Price / Book1.77Miscellaneous Outstanding Shares30,227,000Free Float15,245,000Market Cap$72.85 million OptionableOptionable Beta1.09 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:ZYXI) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.